Fingerprint
Dive into the research topics of 'Phase I, first-in-human study of the Probody therapeutic CX-2029 in adults with advanced solid tumor malignancies'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase I, first-in-human study of the Probody therapeutic CX-2029 in adults with advanced solid tumor malignancies
Melissa Johnson, Anthony El-Khoueiry, Navid Hafez, Nehal Lakhani, Hirva Mamdani, Jordi Rodon, Rachel E. Sanborn, Javier Garcia-Corbacho, Valentina Boni, Mark Stroh, Alison L. Hannah, Song Wang, Henry Castro, Alexander Spira
Research output: Contribution to journal › Article › peer-review